MEDTOX Info

Homepage > MEDTOX Info

MISSION - The right results every day.

VISION - MEDTOX will be nationally-recognized as the leader for the quality, technology and services we provide.

CORE VALUES
   Focus on the Customer
   Demonstrate Integrity & Respect
   Drive Operational Innovation
   Manage Execution
   Energize and Develop People

MEDTOX Scientific, Inc. is comprised of 2 divisions – MEDTOX Laboratories, Inc. (St Paul, MN) and MEDTOX Diagnostics, Inc. (Burlington, NC)

MEDTOX Laboratories contains a full-service clinical laboratory as well as a SAMHSA-certified drug testing laboratory. On the clinical side, MEDTOX offers testing services to physician offices, Clinical Trials sponsors, occupational health clinics, pain management clinics and other health care organizations. On the drug testing side, MEDTOX offers testing services to corporations, clinics and governmental agencies.

MEDTOX Diagnostics is a GMP, ISO-certified manufacturing facility that produces FDA-cleared drug screening devices for use in corporations, hospitals, corrections, rehabilitation facilities and occupational health clinics.

In all of our businesses, MEDTOX is known for Quality, Service and Technology. We strive to partner with our customers and meet their changing needs on a daily basis.

Get to Know MEDTOX Video

NEWS & INSIGHTS

View UPS Shipping Detail

Attention Clients: Important change in implementation date for revisions to HHS and DOT workplace drug testing programs.

SAMHSA has postponed the May 1, 2010 implementation of the revised HHS Mandatory Guidelines for Federal Workplace Drug Testing Programs. The new effective date is October 1, 2010.

The delay was issued to provide sufficient time for the DOT to evaluate comments and issue a final rule harmonizing its regulations with the revised HHS Guidelines in a time frame that will permit implementation of the rules at the same time. This action is welcomed; it will allow HHS-certified laboratories to use the same testing and reporting procedures for Federal workplace and transportation workplace drug testing programs subject to DOT Regulations, avoid the confusion of administering regulatory programs with different requirements and will ensure fairness in treatment of employees subject to the rules.

A notice is posted in the Federal Register for publication on April 30, 2010. The document is available at the Federal Register’s website: Click Here

Workplace Drug Testing Updates